Business Description
Aquarius Surgical Technologies Inc
NAICS : 339110
SIC : 3741
ISIN : CA03842P1009
Compare
Compare
Traded in other countries / regions
ASTI.CanadaAQQRF.USA IPO Date
1989-12-12Description
Aquarius Surgical Technologies Inc is engaged in the development, sale, distribution, marketing, and exploitation of laser-driven technologies for use in surgical environments. Through its subsidiary, the company operates as an international distributor, service, and support organization providing integrated laser-based solutions across multiple medical disciplines. These disciplines include urology, gynecology, ophthalmology, thoracic, ENT, cardiovascular, and neurosurgery, many of which are now considered the standard of care for treatment. Geographically, the company generates maximum revenue from the sale of medical devices in the United States, and also has its presence in Canada.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -3.36 | |||||
Debt-to-Equity | -1.08 | |||||
Debt-to-EBITDA | -30.2 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -27.62 | |||||
Beneish M-Score | -3.82 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -27.9 | |||||
3-Year EBITDA Growth Rate | 24.6 | |||||
3-Year EPS without NRI Growth Rate | 17.8 | |||||
3-Year Book Growth Rate | -18.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 99.8 | |||||
14-Day RSI | 98.33 | |||||
12-1 Month Momentum % | -33.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.06 | |||||
Quick Ratio | 0.06 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 173.81 | |||||
Days Sales Outstanding | 167.42 | |||||
Days Payable | 11493.15 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 54.35 | |||||
Operating Margin % | -279.35 | |||||
Net Margin % | -708.7 | |||||
EBITDA Margin % | -250 | |||||
FCF Margin % | -127.17 | |||||
OCF Margin % | -127.17 | |||||
ROA % | -30.58 | |||||
ROIC % | -10.08 | |||||
3-Year ROIIC % | 26.85 | |||||
ROC (Joel Greenblatt) % | -537.7 | |||||
ROCE % | -89.07 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 5 | |||||
EV-to-EBIT | -30.29 | |||||
EV-to-EBITDA | -32.4 | |||||
EV-to-Revenue | 81 | |||||
EV-to-FCF | -63.69 | |||||
Price-to-GF-Value | 2 | |||||
Earnings Yield (Greenblatt) % | -3.3 | |||||
FCF Yield % | -21.2 |
Aquarius Surgical Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aquarius Surgical Technologies Inc Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2027 | 2027-02-24 | In 184 days | ||
| Second quarter earnings results for 2027 | 2026-12-01 | In 99 days | ||
| First quarter earnings results for 2027 | 2026-08-26 | In 2 days | ||
| General meeting for 2026 | 2026-08-25 | In 1 day | ||
| Annual report for 2026 | 2026-07-27 | 0.01 (+0.00%) | ||
| Third quarter earnings results for 2026 | 2026-02-24 | 0.01 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2025-12-01 | 0.01 (+0.00%) | ||
| First quarter earnings results for 2026 | 2025-08-26 | 0.02 (+0.00%) | ||
| Annual report for 2025 | 2025-07-28 | 0.02 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-02-27 | 0.02 (+0.00%) |
Show
Entries
Press Release
Articles on Aquarius Surgical Technologies Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers